"The Lynn Institute is one of the nation’s most respected clinical trial organizations. We evaluate the latest scientific findings in medications, systems, and treatment models designed to improve the quality of human life."

During the past decade, Lynn Health Science Institute conducted 90 clinical trials. In the 10-year time frame, 90 clinical trials started and 97 clinical trials were completed, i.e. on average, 107.8% percent of trials that started reached the finish line to date. In the past 5 years, 31 clinical trials started and 46 clinical trials were completed. i.e. 148.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lynn Health Science Institute" #1 sponsor was "Pfizer" with 49 trials, followed by "Eli Lilly and Company" with 9 trials sponsored, "ModernaTX, Inc." with 8 trials sponsored, "Endo Pharmaceuticals" with 7 trials sponsored and "Allergan" with 7 trials sponsored. Other sponsors include 121 different institutions and companies that sponsored additional 91 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lynn Health Science Institute" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 3 trials as a collaborator, "Pfizer" with 3 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 2 trials as a collaborator and "CoLucid Pharmaceuticals" with 2 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Lynn Health Science Institute" are "Rheumatoid Arthritis" (14 trials), "Alzheimer's Disease" (11 trials), "Osteoarthritis" (9 trials), "Low Back Pain" (7 trials) and "Arthritis" (5 trials). Many other conditions were trialed in "Lynn Health Science Institute" in a lesser frequency.

Most popular intervention types in "Lynn Health Science Institute" are "Drug" (147 trials), "Biological" (64 trials), "Other" (16 trials), "Device" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (83 trials), "placebo" (11 trials), "Saline" (4 trials), "tanezumab" (4 trials) and "Aducanumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Lynn Health Science Institute" are 194 trials for "All" genders, 8 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Lynn Health Science Institute". undefined are not yet recruiting, 14 are recruiting, 15 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 150 completed trials in Lynn Health Science Institute, undefined suspended trials, and 23 terminated clinical trials to date.

Out of the total trials that were conducted in Lynn Health Science Institute, 9 "Phase 1" clinical trials were conducted, 67 "Phase 2" clinical trials and 120 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 13 trials, and there were also 0 trials that are defined as “Not Applicable".